Lenvatinib - Api

Lenvatinib - Api

100-10000 USD ($)/Unit

Product Details:

X

Price And Quantity

  • 10.00 - 10000.00 USD ($)/Unit
  • 10 Unit
  • 100-10000 USD ($)/Unit

Trade Information

  • Nhava Sheva
  • Others
  • 500-2000 Unit Per Week
  • 15 Days
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer
  • As per customer request
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India
  • WHO,GMP

Product Description

Lenvatinib - Api 

Lenvatinib is a multi-kinase inhibitor that is being investigated for the treatment of various types of cancer by Eisai Co. It inhibits both VEGFR2 and VEGFR3 kinases. The substence was granted orphan drug status for the treatment of various types of thyroid cancer that do not respondtoradioiodine.

Pharmacopoeia: IP/BP

Formula: C21H19ClN4O4

Trade name: Lenvima, Lenvanix

Metabolism: CYP3A4, aldehyde oxidase, non-enzymatic

CAS No: 857890-39-2

Molecular Weight: 426.9 g/mol


VEA IMPEX

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



"We mainly deliver our products to the foreign countries."
Back to top